G6PD deficiency is one of the most common enzymopathies with more than 400 million individuals affected worldwide, mostly men [3]
10.4236/aim.2017.72010 [DOI] [Google Scholar] Shu-Ting C., Philip G
The results showed that the nano-emulsification technique protected the gastric mucosa and alleviated gastric inflammation caused by high consumption of capsaicin
Orforglipron (LY3502970), a novel, oral nonpeptide glucagonlike peptide1 receptor agonist: a Phase 1a, blinded, placebocontrolled, randomized, singleand multipleascendingdose study in healthy participants
Knight and Wright have been diagnosed with severe gastroparesis, or stomach paralysis, which their doctors think may have resulted from or been exacerbated by the medication they were taking, Ozempic